Immuno-prophylaxis of babies borne to hepatitis B carrier mothers

Hong Kong Medical Journal

Volumn 12, Issue 5, 2006, Pages 368-374

  Tse, K ^a   Siu, S L Y ^a   Yip, K T ^a   Chan, S M ^a   Que, T L ^a   Lui, W Y S ^a   Chan, P S ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Hepatitis B e antigens; Hepatitis B surface antigens; Hepatitis B vaccines; Infant, newborn

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B(E) ANTIGEN;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOPROPHYLAXIS; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; MOTHER; NEWBORN; PREVALENCE; VERTICAL TRANSMISSION; VIRUS CARRIER;

CARRIER STATE; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MATERNAL-FETAL EXCHANGE; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 33750073518     PISSN: 10242708     EISSN: 10242708     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733-45.
2. Chang MH. Chronic hepatitis virus infection in children. J Gastroenterol Hepatol 1998;13:541-8.
3. Leung NW. Patterns of viral hepatitis in Hong Kong. Br J Hosp Med 1997;58:166-9.
4. Chiu S, Chow CB, Lau YL, Leung CW. Handbook on childhood immunization in Hong Kong. Hong Kong: Hong Kong Paediatric Foundation; 2000:21.
5. Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study. Lancet 1984;1:921-6.
6. Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis 2004;24(Suppl 1):3S-10S.
7. Torre F, Naoumov NV. Clinical implications of mutations in the hepatitis B virus genome. Eur J Clin Invest 1998;28:604-14.
8. Carman WF, Zanetti AR, Karayiannis P, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990;336:325-9.
9. Zanetti AR, Tanzi E, Manzillo G, et al. Hepatitis B variant in Europe. Lancet 1988;2:1132-3.
10. Oon CJ, Chen WN. Current aspects of hepatitis B surface antigen mutants in Singapore. J Viral Hepat 1998(5 Suppl 2):17S-23S.
11. Tovo PA, Lazier L, Versace A. Hepatitis B virus and hepatitis C virus infections in children. Curr Opin Infect Dis 2005;18:261-6.
12. Lee A, Cheng FF, Chan CS, Lau LC, Lo AS. Sero-epidemiology and risk factors of positive hepatitis B surface antigen amongst Chinese adolescents. Asia Pac J Public Health 2001;13:30-5.
13. Weber B, Bayer A, Kirch P, Schluter V, Schlieper D, Melchior W. Improved detection of hepatitis B virus surface antigen by a new rapid automated assay. J Clin Microbiol 1999;37:2639-47.
14. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - Summary of a workshop. Gastroenterology 2001;120:1828-53.
15. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257:2612-6.
16. Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol 1980;87:958-65.
17. Chen WH, Yin CS, Chang YK, Yan JS, Chu ML. Neonatal gastric aspirates as a predictor of perinatal hepatitis B virus infections. Int J Gynaecol Obstet 1998;60:15-21.
18. Alvarez-Munoz MT, Vazquez-Rosales JG, Torres-Lopez FJ, et al. Infection of pregnant women with hepatitis B and C viruses and risks for vertical transmission. Arch Med Res 1997;28:415-9.
19. Lau GK, Lai CL, Wu PC. The natural history of chronic hepatitis B infection. Hong Kong Med J 1997;3:283-8.
20. Hsu HY, Chang MH, Ni YH, Chen HL. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 2004;53:1499-503.
21. Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 2004;22:2791-9.
22. Rumi MA, Begum K, Hassan MS, et al. Detection of hepatitis B surface antigen in pregnant women attending a public hospital for delivery: implication for vaccination strategy in Bangladesh. Am J Trop Med Hyg 1998;59:318-22.
23. Wang JS, Zhu QR. Infection of the fetus with hepatitis B e antigen via the placenta. Lancet 2000;355:989.
24. Wang Z, Zhang J, Yang H, et al. Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies. J Med Virol 2003;71:360-6.
25. Centers for Disease Control and Prevention (CDC). Hepatitis B vaccination - United States, 1982-2002. MMWR Morb Mortal Wkly Rep 2002;51:549-52.
26. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002;359:1488-9.
27. Li XM, Yang YB, Hou HY, et al. Interruption of HBV intrauterine transmission: a clinical study. World J Gastroenterol 2003;9:1501-3.
28. Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004;10:3215-7.
29. Zhu Q, Yu G, Yu H, et al. A randomized control trial on interruption of HBV transmission in uterus. Chin Med J (Engl) 2003;116:685-7.
30. Mesenas SJ, Chow WC, Zhao YI, Lim GK, Oon CJ, Ng HS. Wild-type and 'a' epitope variants in chronic hepatitis B virus carriers positive for hepatitis B surface antigen and antibody. J Gastroenterol Hepatol 2002;17:148-52.